Ibalisumab effective in in treating multidrug resistant HIV
August 16, 2018Research and Development AIDS, HIV, multidrug resistance, phase 3
The monoclonal antibody Ibalizumab has shown significant antiviral activity against multidrug resistant HIV infections, according to the results of a …
Regenerative process could be restored in liver after severe injuries, study shows
August 16, 2018Research and Development Edinburgh University, liver, mice, research, transplants
Scientists at the University of Edinburgh were able to restore a regenerative response that prevented the need for a liver …
Pfizer partners up with BioNTech for $425m to pursue mRNA flu vaccines
August 16, 2018Research and Development BioNTech, Pfizer, Vaccine, flu, influenza, pharma
Pfizer has announced a partnership with German biotech firm BioNTech after signing a multi-year deal worth $425 million to develop …
Indian biotech owner detained in Dubai over £550m fraud allegations
August 16, 2018Medical Communications Dubai, Gujurat, India, Sterling Biotech, UAE, fraud
Indian businessman Nitin Sandesara, the owner of the Gujarat-based pharmaceutical company Sterling Biotech, has been detained in Dubai in relation …
Realm Therapeutics shares halved after failure of Phase 2 study
August 15, 2018Research and Development London, Shares, atopic dermatitis, phase 2, stock market
Shares in the London-listed Realm Therapeutics plummeted on Monday after the company reported that a Phase II study of the …
Janssen and ViiV’s monthly injectable HIV combo proves non-inferior to daily standard of care
August 15, 2018Research and Development HIV, Janssen, ViiV Healthcare, pharma
Janssen and GSK’s ViiV Healthcare have unveiled strong new Phase 3 data on its two-drug regimen, injected once a month, …
Rotavirus vaccine shown to reduce risk of death by 34% in Malawi
August 15, 2018Research and Development Rotavirus, diarrhoea, malawi, vaccination program, vaccines
A rotavirus vaccine was successful in reducing diarrhoea related deaths in infants in Malawi by 34%, a study led by …
New York sues Purdue Pharma over opioid crisis
August 15, 2018Research and Development Litigation, New York, OxyContin, Purude pharma, opioid crisis, state
New York State have sued OxyContin drug maker Purdue Pharma over allegations surrounding widespread fraud and deception in the marketing …
Gilead CMO announces departure alongside two new exec appointments
August 15, 2018Medical Communications, Research and Development Gilead, pharma
Gilead has announced that its Chief Medical Officer is to vacate the role after just five months and leave the …
Pfizer CMO Charles Hugh-Jones set to join Allergan in return to New Jersey
August 14, 2018The Dublin headquartered multinational, Allergan has appointed Pfizer CMO Charles Hugh-Jones as their new Senior Vice President and Chief Medical …
Fentanyl execution gets go-ahead in federal court
August 14, 2018Manufacturing and Production Nebraska, execution, fatalities, fentanyl, valium
The first execution in the United States using the powerful opioid fentanyl, is set to take place in Nebraska on …
NICE rejects Biogen’s spinal muscular dystrophy drug Spinraza after long delay
August 14, 2018Manufacturing and Production, Sales and Marketing Biogen, NICE, Spinraza, UK, pharma, spinal muscular dystrophy
UK watchdog NICE has rejected Biogen’s spinal muscular dystrophy drug Spinraza (nusinersen) over cost concerns, denying patients the only available …
Researchers design new class of drugs to counter cardiovascular disease
August 14, 2018Manufacturing and Production TMAO, cardiovascular, gut microbe, heart attack, research
Cleveland Clinic researchers have designed a potential new class of drugs that may reduce the risk of cardiovascular disease by …
“Radical radiotherapy” cuts required treatments from 37 to 5
August 14, 2018Manufacturing and Production Cancer, oncology, pharma, radiotherapy
Researchers at Queen’s University Belfast have been trialling a new form of “radical radiotherapy” which can be delivered in just …
Rare lung cancer drug approved in Scotland
August 14, 2018Manufacturing and Production Cancer, SMC, Scotland, Scottish Medicines Consortium, approval, lung cancer
The Scottish Medicines Consortium has approved Roche’s cancer drug alectinib for the treatment of patients with untreated advanced non-small-cell lung …
Working Life: Nawal Ouzren, CEO of Sensorion
August 13, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Sensorion, Working Life, feature, pharma
Pharmafocus caught up with Sensorion CEO Nawal Ouzren to take a look at her path throughout her career and get …
Indicted GOP congressman Chris Collins’ terminates re-election campaign
August 13, 2018Medical Communications, Sales and Marketing Chris Collins, Innate Therapeutics, US, pharma
Indicted republican congressman Chris Collins has performed a U-turn since his arrest on Wednesday under allegations of insider trading, confirming …
Astellas acquires gene therapy group Quethera in £85 million deal
August 13, 2018Sales and Marketing Astellas, Japan, gene therapy, ocular, quethera, vision
The Japanese company Astellas Pharma has acquired British gene therapy group Quethera in a deal worth up to £85 million. …
FDA approves RNA therapy for rare genetic disease
August 13, 2018Sales and Marketing FDA, Onpattro, Orphan Drugs, RNA, rare diseases
The US Food and Drug Administration has approved the RNA-based therapy Onpattro, for the treatment of the rare genetic disease …
Chicago Judge overturns $140 million AbbVie AndroGel verdict
August 13, 2018Sales and Marketing AbbVie, Litigation, androgel, legal, testosterone
A US Judge has overturned a $140.1 million verdict against the New York-listed AbbVie Inc. The verdict, which ruled in …
Latest content
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
